Rchr
J-GLOBAL ID：202101016922686804
Update date: Dec. 24, 2024
Tanaka Tomohiro
タナカ トモヒロ | Tanaka Tomohiro
Affiliation and department：
Research field (2)：
Tumor biology
, Molecular biology
Research theme for competitive and other funds (2)：
- 2024 - 2026 Development of anti-chemokine receptor monoclonal antibody
- 2021 - 2023 Development of cancer specific monoclonal antibody
Papers (104)：
-
Haruto Yamamoto, Yu Kaneko, Tomohiro Tanaka, Guanjie Li, Hiroyuki Suzuki, Mika K. Kaneko, Yukinari Kato. C8Mab-21: A novel anti-human CCR8 monoclonal antibody for flow cytometry. Microbes & Immunity. 2024. 4661-4661
-
Miu Hirose, Hiroyuki Suzuki, Rena Ubukata, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies. Biochemistry and biophysics reports. 2024. 40. 101824-101824
-
Tomohiro Tanaka, Hiroyuki Suzuki, Tomokazu Ohishi, Mika K Kaneko, Yukinari Kato. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Cells. 2024. 13. 22
-
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Guanjie Li, Tomohiro Tanaka, Akira Ohkoshi, Manabu Kawada, Mika Kaneko, et al. Antitumor activities of anti-CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology Reports. 2024. 52. 5
-
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K. Kaneko, Yukio Katori, Yukinari Kato. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International Journal of Molecular Sciences. 2024. 25. 17. 9190-9190
ｍore...
MISC (13)：
-
浅野 禎三, 李 冠傑, 鈴木 裕之, 田中 智大, 金子 美華, 加藤 幸成. CBIS法を用いた新規抗EpCAM抗体の樹立. 日本生化学会大会プログラム・講演要旨集. 2022. 95回. 1P-393
-
田中 智大, 大石 智一, 鈴木 裕之, 金子 美華, 川田 学, 加藤 幸成. 脱フコシル化キメラ抗EGFR抗体の犬がんモデルに対する抗腫瘍効果(Defucosylated mouse-dog chimeric anti-EGFR antibody exerts antitumor activity in canine cancer models). 日本癌学会総会記事. 2022. 81回. P-3047
-
鈴木 裕之, 後藤 のはら, 田中 智大, 金子 美華, 加藤 幸成. 食道がんを標的とした抗CD44モノクローナル抗体の開発(Development of a Novel Anti-CD44 Monoclonal Antibody for Esophageal Squamous Cell Carcinomas). 日本癌学会総会記事. 2022. 81回. P-1163
-
Saito Masaki, Tanaka Tomohiro, Asano Teizo, Suzuki Hiroyuki, K. Kaneko Mika, Kato Yukinari. Development of anti-mouse CC chemokine receptor 8 monoclonal antibody C8Mab-2. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 95. 1-P-095
-
Hiroyuki Suzuki, Li Guanjie, Asano Teizo, Tanaka Tomohiro, Kaneko Mika, Kato Yukinari. Antitumor Activities by a Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody in Canine Tumor Xenograft Models. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 96. 4-B-O12-5
ｍore...
Education (3)：
- - 2018 富山大学大学院 医学薬学教育部 博士後期課程 薬科学専攻
- - 2014 富山大学大学院 医学薬学教育部 博士前期課程 薬科学専攻
- - 2012 University of Toyama Faculty of Pharmacy and Pharmaceutical Sciences Pharmaceutical Sciences
Professional career (1)：
- Ph.D. (Pharmaceutical Science) (University of Toyama)
Work history (4)：
- 2024/04 - 現在 Tohoku University Graduate School of Medicine, Antibody Drug Development
- 2023/01 - 2024/03 Tohoku University
- 2021/01 - 2022/12 Tohoku University Graduate school of medicine, Antibody Drug Development
- 2018/04 - 2020/12 株式会社LSIメディエンス 試験研究センター 薬理研究部
Awards (1)：
- 2024/08 - 第28回日本がん分子標的治療学会学術集会 優秀ポスター賞
Return to Previous Page
